Enhanced CRISPR/Cas9 Genome Editing in Heart and Skeletal Muscle with a Potent New AAV Variant
Publication
, Conference
Gonzalez, TJ; Blondel, L; Rosales, A; Daniels, H; Gersbach, CA; Asokan, A
Published in: MOLECULAR THERAPY
2022
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
211 / 212
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Gonzalez, T. J., Blondel, L., Rosales, A., Daniels, H., Gersbach, C. A., & Asokan, A. (2022). Enhanced CRISPR/Cas9 Genome Editing in Heart and Skeletal Muscle with a Potent New AAV Variant. In MOLECULAR THERAPY (Vol. 30, pp. 211–212).
Gonzalez, Trevor J., Leo Blondel, Alan Rosales, Heather Daniels, Charles A. Gersbach, and Aravind Asokan. “Enhanced CRISPR/Cas9 Genome Editing in Heart and Skeletal Muscle with a Potent New AAV Variant.” In MOLECULAR THERAPY, 30:211–12, 2022.
Gonzalez TJ, Blondel L, Rosales A, Daniels H, Gersbach CA, Asokan A. Enhanced CRISPR/Cas9 Genome Editing in Heart and Skeletal Muscle with a Potent New AAV Variant. In: MOLECULAR THERAPY. 2022. p. 211–2.
Gonzalez, Trevor J., et al. “Enhanced CRISPR/Cas9 Genome Editing in Heart and Skeletal Muscle with a Potent New AAV Variant.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 211–12.
Gonzalez TJ, Blondel L, Rosales A, Daniels H, Gersbach CA, Asokan A. Enhanced CRISPR/Cas9 Genome Editing in Heart and Skeletal Muscle with a Potent New AAV Variant. MOLECULAR THERAPY. 2022. p. 211–212.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2022
Volume
30
Issue
4
Start / End Page
211 / 212
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences